Anand Vaidya
Overview
Explore the profile of Anand Vaidya including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
216
Citations
3394
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hamnvik O, Vaidya A, Siegel J, Irwig M
N Engl J Med
. 2025 Mar;
392(11):e30.
PMID: 40073313
No abstract available.
2.
Parisien-La Salle S, Brown J, Mahrokhian S, Hanna I, Honzel B, Tsai L, et al.
J Clin Endocrinol Metab
. 2025 Mar;
PMID: 40036317
Background: A continuum of non-suppressible aldosterone production has been demonstrated in normotensive individuals, termed subclinical primary aldosteronism (PA), and is consistently associated with increased risk for developing hypertension and cardiovascular...
3.
Brown J, Tsai L, Abel E, Ferrebus A, Moore A, Niebuhr Y, et al.
Hypertension
. 2025 Feb;
PMID: 39981578
Background: Primary aldosteronism, an endocrinopathy present in ≥10% to 25% of patients with hypertension, confers excess cardiovascular risk that can be mitigated with aldosterone-directed therapy. However, only 2% of eligible...
4.
Vaidya A, Morlote M, Moussa M, Barletta J, Nehs M
N Engl J Med
. 2025 Jan;
392(4):e14.
PMID: 39842014
No abstract available.
5.
Tsai C, Liao C, Wu X, Chen Z, Pan C, Chang Y, et al.
Eur J Endocrinol
. 2025 Jan;
192(2):81-90.
PMID: 39827466
Background: Mild autonomous cortisol secretion (MACS) is common in adrenal adenomas, including patients with primary aldosteronism (PA) with aldosterone-producing adenomas (APA). This study investigated the impact of MACS on cardiac...
6.
Yang J, Burrello J, Goi J, Reincke M, Adolf C, Asbach E, et al.
Lancet Diabetes Endocrinol
. 2025 Jan;
13(2):119-133.
PMID: 39824204
Background: Primary aldosteronism can be treated medically but there is no standardised method to evaluate treatment outcomes. We aimed to develop criteria for assessing the outcomes of targeted medical treatment...
7.
Chen U, Liao C, Wang S, Lai T, Huang K, Chang C, et al.
J Clin Endocrinol Metab
. 2025 Jan;
PMID: 39745835
Context: The captopril challenge test (CCT) is a commonly used confirmation test that identifies the magnitude of renin- and angiotensin II-independent aldosterone production, and thus the presence and severity of...
8.
Brown J, Honzel B, Tsai L, Milks J, Neibuhr Y, Neibuhr Y, et al.
Hypertension
. 2024 Dec;
82(2):306-318.
PMID: 39660429
Background: Renin-independent aldosterone production in normotensive people increases risk for developing hypertension. In parallel, normotensive adrenal glands frequently harbor aldosterone-producing micronodules with pathogenic somatic mutations known to induce primary aldosteronism...
9.
Teklu M, Vaidya A, Yonar M, Kim J, Kim E
N Engl J Med
. 2024 Nov;
391(19):e43.
PMID: 39536230
No abstract available.
10.
Eiger D, Vaidya A, Hanberg J, Clark R, Eisenberg S
N Engl J Med
. 2024 Sep;
391(12):e25.
PMID: 39321366
No abstract available.